Last updated 12 days ago

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

300 patients around the world
Available in Argentina, United States
Janssen Research & Development, LLC
5Research sites
300Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto Argentino de Diagnóstico y Tratamiento - IADT
Recruiting
Marcelo Torcuato de Alvear 2346, C1122 CABA
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
Juan Domingo Perón 4190, Piso 1, Ciudad Autónoma de Buenos Aires, C1181ACH
Hospital Privado de la Comunidad
Recruiting
Córdoba 4545, Mar del Plata, Buenos Aires
Centro Médico Austral OMI - CABA
Recruiting
Montevideo 955, C1019ABS Cdad. Autónoma de Buenos Aires, Argentina
Hospital Italiano de La Plata
Recruiting
Av. 51 entre 29 y 30 Nro 1725, La Plata, Buenos Aires
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy